23 June 2020 : Clinical Research
The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis
Mei Tian1BE, Xiuchun Yang1CD, Yanfang Li1BF, Sen Guo2ABCDEFG*DOI: 10.12659/MSM.923359
Med Sci Monit 2020; 26:e923359
Table 4 Multivariate analysis was performed to confirm the independent prognostic factors.
| Characters | HR | 95% CI | P* |
|---|---|---|---|
| Tumor size (cm) | |||
| ≤5 | 1 | ||
| >5 | 1.21 | 0.74–1.98 | 0.446 |
| Vascular invasion | |||
| Negative | 1 | ||
| Positive | 1.51 | 0.98–2.31 | 0.06 |
| T stage | |||
| I+II | 1 | ||
| III+IV | 2.90 | 1.80–4.69 | <0.001 |
| Dynamin 1 | |||
| Low | 1 | ||
| High | 2.06 | 1.36–3.12 | 0.001 |
| * Analyzed with the Cox-regression model. HBsAg – hepatitis B surface antigen; HCV – hepatitis C virus; AFP – alpha fetoprotein; HR – harzrd ratio; CI – confidential incidence. | |||